dimethylformamide has been researched along with EHS Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dexter, DL | 1 |
| Kobayashi, GS; Medoff, G; Schlessinger, D | 1 |
2 other study(ies) available for dimethylformamide and EHS Tumor
| Article | Year |
|---|---|
N,N-Dimethylformamide-induced morphological differentiation and reduction of tumorigenicity in cultured mouse rhabdomyosarcoma cells.
Topics: Animals; Bucladesine; Cell Differentiation; Cell Division; Cell Survival; Cells, Cultured; Dimethylformamide; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Rhabdomyosarcoma; Sarcoma, Experimental; Transplantation, Homologous | 1977 |
Sensitivity of transformed and nontransformed cells to amphotericin B and several rifamycin derivatives.
Topics: Amphotericin B; Animals; Cell Line; Cell Transformation, Neoplastic; Cells, Cultured; Dimethylformamide; Drug Synergism; Ethanol; Gammaretrovirus; Mice; Mice, Inbred BALB C; Rifamycins; Sarcoma, Experimental | 1974 |